European Union - English - EMA (European Medicines Agency)

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - lenacapavir sodium, quantity: 473.1 mg (equivalent: lenacapavir, qty 463.5 mg) - injection, solution - excipient ingredients: macrogol 300; water for injections - sunlenca, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

Australia - English - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - lenacapavir sodium, quantity: 306.8 mg (equivalent: lenacapavir, qty 300 mg) - tablet, film coated - excipient ingredients: copovidone; poloxamer; mannitol; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - sunlenca, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

Canada - English - Health Canada

janssen inc - simeprevir (simeprevir sodium) - capsule - 150mg - simeprevir (simeprevir sodium) 150mg - hcv protease inhibitors